Rebamipide

Records for this ingredient, by country (identity only).

ATC A02BX · 2 markets · 99 records

Rebamipide 2 markets · 99 records Forms
Filters
MarketCN 93JP 6

CN 93 records · 2 shown of 2 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 100 mgtablet膜固思达瑞巴派特Manufacturer: 北京金城泰尔制药有限公司、Manufacturer: 四川美大康华康药业有限公司、Manufacturer: 广东华南药业集团有限公司、Manufacturer: 成都倍特药业股份有限公司、Manufacturer: 杭州沐源生物医药科技有限公司、Manufacturer: 浙江远力健药业有限责任公司、Manufacturer: 海南科进生物制药有限公司、Manufacturer: 福安药业集团宁波天衡制药有限公司 +5 also in JP
  • 100 mgcapsuleManufacturer: 重庆圣华曦药业股份有限公司 ×8

JP 6 records · 4 shown of 4 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 100 mgtabletムコスタ錠100mgレバミピド100mg口腔内崩壊錠、レバミピド100mg錠 also in CN
  • 20 %/1 gpowderレバミピド顆粒20%「タカタ」
  • 2 %/0.35 mLophthalmicムコスタ点眼液UD2%
  • 2 %/5 mLophthalmicレバミピド懸濁性点眼液2%「参天」
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.